CoChat
Sign Up
Cited by 129

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells

Welner, Robert S., Amabile, Giovanni, Bararia, Deepak, Czibere, Akos, Yang, Henry, Zhang, Hong, Pontes, Lorena Lobo De Figueiredo, Ye, Min, Levantini, Elena, Di Ruscio, Annalisa, Martinelli, Giovanni, Tenen, Daniel G.·2015·Cancer Cell
DOI 10.1016/j.ccell.2015.04.004PMC PMC4447336
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2015.04.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 47

  1. Anand, 1998, Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis, Hematol. Oncol., 16, 143, 10.1002/(SICI)1099-1069(199812)16:4<143::AID-HON628>3.0.CO;2-U · DOI
  2. Ben-Neriah, 1986, The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene, Science, 233, 212, 10.1126/science.3460176 · DOI
  3. Cappella, 2008, A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining, Cytometry A, 73, 626, 10.1002/cyto.a.20582 · DOI
  4. Cashman, 1998, MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures, Blood, 92, 2338, 10.1182/blood.V92.7.2338 · DOI
  5. Challen, 2009, Mouse hematopoietic stem cell identification and analysis, Cytometry A, 75, 14, 10.1002/cyto.a.20674 · DOI
  6. Colmone, 2008, Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells, Science, 322, 1861, 10.1126/science.1164390 · DOI · Paper page
  7. Dazzi, 1998, The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor’s disease: an in vivo model of chronic myelogenous leukemia biology, Blood, 92, 1390, 10.1182/blood.V92.4.1390 · DOI
  8. Eaves, 1993, The biology of normal and neoplastic stem cells in CML, Leuk. Lymphoma, 11, 245, 10.3109/10428199309047894 · DOI
  9. Eaves, 1993, Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells, Proc. Natl. Acad. Sci. USA, 90, 12015, 10.1073/pnas.90.24.12015 · DOI
  10. Fialkow, 1977, Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage, Am. J. Med., 63, 125, 10.1016/0002-9343(77)90124-3 · DOI
  11. Hartwell, 2013, Niche-based screening identifies small-molecule inhibitors of leukemia stem cells, Nat. Chem. Biol., 9, 840, 10.1038/nchembio.1367 · DOI
  12. Heidel, 2012, Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML, Cell Stem Cell, 10, 412, 10.1016/j.stem.2012.02.017 · DOI
  13. Holyoake, 1999, Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia, Blood, 94, 2056, 10.1182/blood.V94.6.2056 · DOI
  14. Hooberman, 1989, Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia, Proc. Natl. Acad. Sci. USA, 86, 4259, 10.1073/pnas.86.11.4259 · DOI
  15. Hu, 2006, Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice, Proc. Natl. Acad. Sci. USA, 103, 16870, 10.1073/pnas.0606509103 · DOI
  16. Hu, 2009, Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model, Blood, 114, 3783, 10.1182/blood-2009-06-227843 · DOI
  17. Kiel, 2005, SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells, Cell, 121, 1109, 10.1016/j.cell.2005.05.026 · DOI · Paper page
  18. Kleppe, 2015, JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response, Cancer Discov., 5, 316, 10.1158/2159-8290.CD-14-0736 · DOI
  19. Koschmieder, 2005, Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis, Blood, 105, 324, 10.1182/blood-2003-12-4369 · DOI · Paper page
  20. Krause, 2013, Differential regulation of myeloid leukemias by the bone marrow microenvironment, Nat. Med., 19, 1513, 10.1038/nm.3364 · DOI
  21. Levine, 2008, Myeloproliferative disorders, Blood, 112, 2190, 10.1182/blood-2008-03-077966 · DOI
  22. Maeda, 2005, IL-6 blocks a discrete early step in lymphopoiesis, Blood, 106, 879, 10.1182/blood-2005-02-0456 · DOI
  23. Maguer-Satta, 1996, BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia, Blood, 88, 1796, 10.1182/blood.V88.5.1796.1796 · DOI
  24. Mayle, 2013, Flow cytometry analysis of murine hematopoietic stem cells, Cytometry A, 83, 27, 10.1002/cyto.a.22093 · DOI
  25. Mercier, 2012, The bone marrow at the crossroads of blood and immunity, Nat. Rev. Immunol., 12, 49, 10.1038/nri3132 · DOI
  26. Mohtashami, 2010, Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes, J. Immunol., 185, 867, 10.4049/jimmunol.1000782 · DOI
  27. Petzer, 1996, Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia, Blood, 88, 2162, 10.1182/blood.V88.6.2162.bloodjournal8862162 · DOI
  28. Savona, 2008, Getting to the stem of chronic myeloid leukaemia, Nat. Rev. Cancer, 8, 341, 10.1038/nrc2368 · DOI
  29. Sawyers, 1999, Chronic myeloid leukemia, N. Engl. J. Med., 340, 1330, 10.1056/NEJM199904293401706 · DOI
  30. Schemionek, 2010, BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells, Blood, 115, 3185, 10.1182/blood-2009-04-215376 · DOI · Paper page
  31. Schepers, 2013, Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche, Cell Stem Cell, 13, 285, 10.1016/j.stem.2013.06.009 · DOI · Paper page
  32. Schmidt, 2011, Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia, Cancer Cell, 19, 740, 10.1016/j.ccr.2011.05.007 · DOI
  33. Spangrude, 1995, Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function, Blood, 85, 1006, 10.1182/blood.V85.4.1006.bloodjournal8541006 · DOI
  34. Staber, 2013, Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells, Mol. Cell, 49, 934, 10.1016/j.molcel.2013.01.007 · DOI · Paper page
  35. Szilvassy, 1990, Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy, Proc. Natl. Acad. Sci. USA, 87, 8736, 10.1073/pnas.87.22.8736 · DOI
  36. Tanaka, 2011, Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases, FEBS Lett., 585, 3699, 10.1016/j.febslet.2011.03.023 · DOI
  37. Venezia, 2004, Molecular signatures of proliferation and quiescence in hematopoietic stem cells, PLoS Biol., 2, e301, 10.1371/journal.pbio.0020301 · DOI
  38. Wang, 1998, High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase, Blood, 91, 2406, 10.1182/blood.V91.7.2406 · DOI
  39. Wang, 2005, Lymphoid potential of primitive bone marrow progenitors evaluated in vitro, Ann. N Y Acad. Sci., 1044, 210, 10.1196/annals.1349.026 · DOI
  40. Warr, 2011, Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies, Wiley Interdiscip. Rev. Syst. Biol. Med., 3, 681, 10.1002/wsbm.145 · DOI · Paper page
  41. Welner, 2008, Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection, Blood, 112, 3753, 10.1182/blood-2008-04-151506 · DOI
  42. Witte, 1988, Closely related BCR/ABL oncogenes are associated with the distinctive clinical biologies of Philadelphia chromosome positive chronic myelogenous and acute lymphocytic leukemia, Curr. Top. Microbiol. Immunol., 141, 42
  43. Zhang, 1998, Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia, Blood, 92, 3829, 10.1182/blood.V92.10.3829.422k14_3829_3840 · DOI
  44. Zhang, 2010, Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate, Cancer Cell, 17, 427, 10.1016/j.ccr.2010.03.011 · DOI
  45. Zhang, 2012, Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia, Cancer Cell, 21, 577, 10.1016/j.ccr.2012.02.018 · DOI
  46. Zhao, 2007, Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo, Cancer Cell, 12, 528, 10.1016/j.ccr.2007.11.003 · DOI
  47. Zhao, 2014, Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis, Cell Stem Cell, 14, 445, 10.1016/j.stem.2014.01.007 · DOI · Paper page

Cited by

Metadata

Authors
Welner, R. S., Amabile, G., Bararia, D., Czibere, A., Yang, H., Zhang, H., Pontes, L. L. D. F., Ye, M., Levantini, E., Di Ruscio, A., Martinelli, G., & Tenen, D. G.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2015-05
Volume
27
Issue
5
Pages
671-681
ISSN
1535-6108
DOI
10.1016/j.ccell.2015.04.004
PMC
PMC4447336
Cited by
129
References
6
Language
en
Licence
Funders
  • National Medical Research Council
  • Ministry of Health -Singapore
  • National Research Foundation Singapore
  • Ministry of Education - Singapore
  • José Carreras Leukämie-Stiftung (1K99CA188595-01, FIJC F11/01)
  • National Institutes of Health (CA66996, HL112719)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review